Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 5.43728046 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.43728046 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.26290295 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.20158000 |
5 | modulation by symbiont of host immune response (GO:0052553) | 5.20158000 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.20158000 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.20158000 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.20158000 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.20158000 |
10 | synaptic vesicle exocytosis (GO:0016079) | 5.10258080 |
11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.07482632 |
12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.00163770 |
13 | macrophage activation involved in immune response (GO:0002281) | 4.91142635 |
14 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.89980072 |
15 | glutamate secretion (GO:0014047) | 4.75912261 |
16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.75090735 |
17 | synaptic vesicle maturation (GO:0016188) | 4.72190839 |
18 | detection of molecule of bacterial origin (GO:0032490) | 4.71973123 |
19 | vocalization behavior (GO:0071625) | 4.68645097 |
20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.64347569 |
21 | microglial cell activation (GO:0001774) | 4.64082230 |
22 | locomotory exploration behavior (GO:0035641) | 4.53747332 |
23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.46883841 |
24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.37650998 |
25 | cellular extravasation (GO:0045123) | 4.34960221 |
26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.34062972 |
27 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.25787283 |
28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.23826991 |
29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.20562378 |
30 | regulation of synaptic vesicle transport (GO:1902803) | 4.17155768 |
31 | neurotransmitter secretion (GO:0007269) | 4.16963899 |
32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.11625142 |
33 | protein localization to synapse (GO:0035418) | 4.10788788 |
34 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.07282005 |
35 | neuronal action potential propagation (GO:0019227) | 4.03019860 |
36 | macrophage activation (GO:0042116) | 4.01552475 |
37 | neutrophil activation involved in immune response (GO:0002283) | 3.96675174 |
38 | detection of other organism (GO:0098543) | 3.95904609 |
39 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.94331400 |
40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91280093 |
41 | detection of external biotic stimulus (GO:0098581) | 3.88228433 |
42 | negative regulation of interleukin-12 production (GO:0032695) | 3.85689006 |
43 | response to peptidoglycan (GO:0032494) | 3.81824110 |
44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78441581 |
45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75615821 |
46 | synaptic transmission, glutamatergic (GO:0035249) | 3.74615408 |
47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.74295483 |
48 | glutamate receptor signaling pathway (GO:0007215) | 3.71242830 |
49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.67998069 |
50 | neuron-neuron synaptic transmission (GO:0007270) | 3.66028434 |
51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62465900 |
52 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.61899137 |
53 | response to host immune response (GO:0052572) | 3.60372202 |
54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.60372202 |
55 | neutrophil mediated immunity (GO:0002446) | 3.57221544 |
56 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.53939805 |
57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50484369 |
58 | neuron cell-cell adhesion (GO:0007158) | 3.49901411 |
59 | myeloid cell activation involved in immune response (GO:0002275) | 3.48882432 |
60 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.47800733 |
61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.46658070 |
62 | detection of bacterium (GO:0016045) | 3.45369738 |
63 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.45098656 |
64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.44413254 |
65 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.44287030 |
66 | neutrophil activation (GO:0042119) | 3.44080072 |
67 | gamma-aminobutyric acid transport (GO:0015812) | 3.43928757 |
68 | detection of biotic stimulus (GO:0009595) | 3.43371740 |
69 | cellular potassium ion homeostasis (GO:0030007) | 3.43317638 |
70 | response to interleukin-15 (GO:0070672) | 3.42723210 |
71 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.42274977 |
72 | regulation of synapse structural plasticity (GO:0051823) | 3.41668654 |
73 | response to histamine (GO:0034776) | 3.40889935 |
74 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.38915200 |
75 | positive regulation of mast cell activation (GO:0033005) | 3.38255220 |
76 | exploration behavior (GO:0035640) | 3.37368616 |
77 | cerebellar granule cell differentiation (GO:0021707) | 3.36199591 |
78 | response to host (GO:0075136) | 3.35075339 |
79 | response to host defenses (GO:0052200) | 3.35075339 |
80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.35075339 |
81 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33337799 |
82 | membrane depolarization during action potential (GO:0086010) | 3.30104208 |
83 | myeloid leukocyte mediated immunity (GO:0002444) | 3.28831058 |
84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.28055920 |
85 | proline transport (GO:0015824) | 3.26629425 |
86 | long-term synaptic potentiation (GO:0060291) | 3.26460331 |
87 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.25646293 |
88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21804809 |
89 | regulation of postsynaptic membrane potential (GO:0060078) | 3.21757157 |
90 | neurotransmitter transport (GO:0006836) | 3.21080963 |
91 | cellular response to interleukin-15 (GO:0071350) | 3.17068046 |
92 | positive regulation of membrane potential (GO:0045838) | 3.16077313 |
93 | sodium ion export (GO:0071436) | 3.15920765 |
94 | presynaptic membrane assembly (GO:0097105) | 3.15569410 |
95 | long-term memory (GO:0007616) | 3.14938975 |
96 | regulation of neurotransmitter secretion (GO:0046928) | 3.13887203 |
97 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.12427363 |
98 | granulocyte activation (GO:0036230) | 3.10354462 |
99 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10255339 |
100 | respiratory burst (GO:0045730) | 3.09900870 |
101 | B cell receptor signaling pathway (GO:0050853) | 3.09762714 |
102 | synaptic vesicle endocytosis (GO:0048488) | 3.09094567 |
103 | leukocyte aggregation (GO:0070486) | 3.07786846 |
104 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.07352533 |
105 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05467600 |
106 | regulation of mast cell degranulation (GO:0043304) | 3.04508160 |
107 | activation of protein kinase A activity (GO:0034199) | 3.03996776 |
108 | postsynaptic membrane organization (GO:0001941) | 3.02208456 |
109 | germinal center formation (GO:0002467) | 3.01549025 |
110 | response to auditory stimulus (GO:0010996) | 2.99950004 |
111 | regulation of neurotransmitter levels (GO:0001505) | 2.99719627 |
112 | activated T cell proliferation (GO:0050798) | 2.99447525 |
113 | regulation of mast cell activation (GO:0033003) | 2.98686168 |
114 | response to muramyl dipeptide (GO:0032495) | 2.97091861 |
115 | positive regulation of mast cell degranulation (GO:0043306) | 2.96092336 |
116 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.96092336 |
117 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.95551926 |
118 | cell communication by electrical coupling (GO:0010644) | 2.94891399 |
119 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.94664428 |
120 | immunoglobulin mediated immune response (GO:0016064) | 2.94546620 |
121 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.93743066 |
122 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93479217 |
123 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93096794 |
124 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93063625 |
125 | membrane depolarization (GO:0051899) | 2.92236329 |
126 | positive regulation of neurotransmitter transport (GO:0051590) | 2.91731079 |
127 | negative thymic T cell selection (GO:0045060) | 2.89329309 |
128 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.88282844 |
129 | negative T cell selection (GO:0043383) | 2.88119192 |
130 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.87883846 |
131 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.87869008 |
132 | presynaptic membrane organization (GO:0097090) | 2.87752101 |
133 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.87750921 |
134 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.87521088 |
135 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.87317382 |
136 | regulation of neurotransmitter transport (GO:0051588) | 2.85982608 |
137 | positive thymic T cell selection (GO:0045059) | 2.85384987 |
138 | positive regulation of synapse maturation (GO:0090129) | 2.84067798 |
139 | neuromuscular process controlling posture (GO:0050884) | 2.83506920 |
140 | regulation of synaptic plasticity (GO:0048167) | 2.83152326 |
141 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81008747 |
142 | regulation of vesicle fusion (GO:0031338) | 2.80663391 |
143 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.79491357 |
144 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.79280747 |
145 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.76995042 |
146 | mechanosensory behavior (GO:0007638) | 2.76331059 |
147 | auditory behavior (GO:0031223) | 2.76040078 |
148 | regulation of leukocyte degranulation (GO:0043300) | 2.75916272 |
149 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75362007 |
150 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75277375 |
151 | regulation of ARF protein signal transduction (GO:0032012) | 2.73949429 |
152 | positive regulation of synaptic transmission (GO:0050806) | 2.73915133 |
153 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.73713335 |
154 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73526817 |
155 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72632356 |
156 | synaptic transmission (GO:0007268) | 2.71749958 |
157 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.71663486 |
158 | positive T cell selection (GO:0043368) | 2.69803388 |
159 | regulation of regulated secretory pathway (GO:1903305) | 2.67450383 |
160 | glycine transport (GO:0015816) | 2.66585087 |
161 | myeloid leukocyte activation (GO:0002274) | 2.65209689 |
162 | cellular response to ethanol (GO:0071361) | 2.64813561 |
163 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.64395931 |
164 | defense response to protozoan (GO:0042832) | 2.64015199 |
165 | detection of calcium ion (GO:0005513) | 2.63684339 |
166 | cell differentiation in hindbrain (GO:0021533) | 2.63539072 |
167 | membrane hyperpolarization (GO:0060081) | 2.62682060 |
168 | long term synaptic depression (GO:0060292) | 2.62585656 |
169 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.62171002 |
170 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.62171002 |
171 | regulation of cell communication by electrical coupling (GO:0010649) | 2.61542808 |
172 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61453369 |
173 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60895016 |
174 | regulation of beta-amyloid formation (GO:1902003) | 2.59993187 |
175 | leukocyte degranulation (GO:0043299) | 2.58905947 |
176 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.57234561 |
177 | dendritic cell migration (GO:0036336) | 2.56670967 |
178 | synapse assembly (GO:0007416) | 2.56431067 |
179 | T-helper 1 type immune response (GO:0042088) | 2.56360692 |
180 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.55226819 |
181 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.54793980 |
182 | urinary tract smooth muscle contraction (GO:0014848) | 2.54612152 |
183 | positive regulation of interferon-alpha production (GO:0032727) | 2.54487054 |
184 | negative regulation of B cell mediated immunity (GO:0002713) | 2.54356754 |
185 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.54356754 |
186 | striatum development (GO:0021756) | 2.54002687 |
187 | negative regulation of adaptive immune response (GO:0002820) | 2.53766696 |
188 | regulation of tolerance induction (GO:0002643) | 2.53759026 |
189 | response to type I interferon (GO:0034340) | 2.53247783 |
190 | positive regulation of macrophage cytokine production (GO:0060907) | 2.53001769 |
191 | regulation of synapse maturation (GO:0090128) | 2.50473895 |
192 | regulation of synaptic transmission (GO:0050804) | 2.49050476 |
193 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.48880320 |
194 | negative regulation of dendrite development (GO:2000171) | 2.48457841 |
195 | behavioral response to cocaine (GO:0048148) | 2.47854443 |
196 | vesicle transport along microtubule (GO:0047496) | 2.45061519 |
197 | prepulse inhibition (GO:0060134) | 2.44738399 |
198 | establishment of synaptic vesicle localization (GO:0097480) | 2.43845477 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.36120359 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.26864253 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63110160 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.39925911 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.24483725 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.12440244 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.69754984 |
8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.63517545 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59829180 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56802571 |
11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50248130 |
12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.42870119 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42296070 |
14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39984062 |
15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.39441257 |
16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.36617574 |
17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.31589457 |
18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19824929 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15044728 |
20 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12142428 |
21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.12028409 |
22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.08247257 |
23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.08247257 |
24 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06771978 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05138223 |
26 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.03659009 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.01276406 |
28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00682342 |
29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99316953 |
30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.98826607 |
31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.98312309 |
32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97141584 |
33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96548732 |
34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.95282642 |
35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90751777 |
36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.90652818 |
37 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90411055 |
38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86319003 |
39 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85954332 |
40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78756781 |
41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78177979 |
42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76385039 |
43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75538730 |
44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73703436 |
45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71272399 |
46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69056305 |
47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68272517 |
48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.67929166 |
49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63365434 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63322632 |
51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62686006 |
52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62490385 |
53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60023667 |
54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57662465 |
55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57269738 |
56 | MYB_26560356_Chip-Seq_TH2_Human | 1.57195151 |
57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55352520 |
58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.52736811 |
59 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49832269 |
60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47127030 |
61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38985571 |
62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37209824 |
63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37101163 |
64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35862740 |
65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35263131 |
66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34206847 |
67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33474266 |
68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33428450 |
69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33121086 |
70 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32844641 |
71 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30833620 |
72 | * TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30639819 |
73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30553881 |
74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29061125 |
75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28088932 |
76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27808504 |
77 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27623647 |
78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26408710 |
79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25674260 |
80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.24260873 |
81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23822167 |
82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23058740 |
83 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22692468 |
84 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.21915146 |
85 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20461177 |
86 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20230872 |
87 | AR_19668381_ChIP-Seq_PC3_Human | 1.18542086 |
88 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.17312757 |
89 | * MYB_26560356_Chip-Seq_TH1_Human | 1.16623185 |
90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15751701 |
91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14066903 |
92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.13735268 |
93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13152621 |
94 | MAF_26560356_Chip-Seq_TH1_Human | 1.12665734 |
95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12292650 |
96 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11428997 |
97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10749698 |
98 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10130693 |
99 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09260292 |
100 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09250338 |
101 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09193700 |
102 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08768591 |
103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08000453 |
104 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07763574 |
105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06056577 |
106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05778733 |
107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05673247 |
108 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05316237 |
109 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05199054 |
110 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05089141 |
111 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04955309 |
112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04831887 |
113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03603660 |
114 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03206584 |
115 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02895400 |
116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02443708 |
117 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99932033 |
118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99427423 |
119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99064312 |
120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98968892 |
121 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98187991 |
122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97676933 |
123 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97299825 |
124 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97118518 |
125 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96979968 |
126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96929633 |
127 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96032817 |
128 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94679166 |
129 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94216843 |
130 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93726123 |
131 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93128923 |
132 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93118267 |
133 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92769195 |
134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92539561 |
135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92491925 |
136 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92464211 |
137 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92361252 |
138 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91966812 |
139 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91723596 |
140 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91694442 |
141 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91574966 |
142 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91001451 |
143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90913035 |
144 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90517126 |
145 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90208847 |
146 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90162928 |
147 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90103694 |
148 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89796197 |
149 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89536539 |
150 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88905102 |
151 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88905102 |
152 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88880274 |
153 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88529727 |
154 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88382695 |
155 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88133719 |
156 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87521594 |
157 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87064544 |
158 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.87020889 |
159 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86886192 |
160 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86381445 |
161 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85704701 |
162 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84708097 |
163 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84379887 |
164 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81619512 |
165 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79619797 |
166 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78266074 |
167 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76712769 |
168 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75862880 |
169 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75405802 |
170 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.75242112 |
171 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.69655631 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.08826783 |
2 | MP0003724_increased_susceptibility_to | 4.67954303 |
3 | MP0003880_abnormal_central_pattern | 3.75563502 |
4 | MP0009046_muscle_twitch | 3.64452907 |
5 | MP0003635_abnormal_synaptic_transmissio | 3.62303330 |
6 | MP0001968_abnormal_touch/_nociception | 3.53824998 |
7 | MP0003436_decreased_susceptibility_to | 3.32589154 |
8 | MP0009745_abnormal_behavioral_response | 3.28974273 |
9 | MP0002064_seizures | 3.03925048 |
10 | MP0002736_abnormal_nociception_after | 3.01599812 |
11 | MP0002822_catalepsy | 2.95417241 |
12 | MP0004270_analgesia | 2.90193508 |
13 | MP0002063_abnormal_learning/memory/cond | 2.86922626 |
14 | MP0002419_abnormal_innate_immunity | 2.72319205 |
15 | MP0002735_abnormal_chemical_nociception | 2.65303980 |
16 | MP0002572_abnormal_emotion/affect_behav | 2.56362011 |
17 | MP0001800_abnormal_humoral_immune | 2.52917761 |
18 | MP0002734_abnormal_mechanical_nocicepti | 2.47490232 |
19 | MP0002272_abnormal_nervous_system | 2.46695498 |
20 | MP0005025_abnormal_response_to | 2.38609725 |
21 | MP0000685_abnormal_immune_system | 2.38337717 |
22 | MP0005000_abnormal_immune_tolerance | 2.27056833 |
23 | MP0006082_CNS_inflammation | 2.25843962 |
24 | MP0002723_abnormal_immune_serum | 2.22704698 |
25 | MP0001501_abnormal_sleep_pattern | 2.17564934 |
26 | MP0001486_abnormal_startle_reflex | 2.12436089 |
27 | MP0002067_abnormal_sensory_capabilities | 2.11658428 |
28 | MP0002452_abnormal_antigen_presenting | 2.10715216 |
29 | MP0002420_abnormal_adaptive_immunity | 2.07050066 |
30 | MP0001819_abnormal_immune_cell | 2.04746634 |
31 | MP0003300_gastrointestinal_ulcer | 2.03801512 |
32 | MP0008569_lethality_at_weaning | 1.97107905 |
33 | MP0001970_abnormal_pain_threshold | 1.89841692 |
34 | MP0004510_myositis | 1.88180293 |
35 | MP0005646_abnormal_pituitary_gland | 1.85891616 |
36 | MP0001984_abnormal_olfaction | 1.85696844 |
37 | MP0009780_abnormal_chondrocyte_physiolo | 1.84927930 |
38 | MP0002733_abnormal_thermal_nociception | 1.83396312 |
39 | MP0004924_abnormal_behavior | 1.82436858 |
40 | MP0005386_behavior/neurological_phenoty | 1.82436858 |
41 | MP0003646_muscle_fatigue | 1.81592828 |
42 | MP0003828_pulmonary_edema | 1.80176560 |
43 | MP0003191_abnormal_cellular_cholesterol | 1.78870895 |
44 | MP0001440_abnormal_grooming_behavior | 1.78033447 |
45 | MP0001533_abnormal_skeleton_physiology | 1.73486335 |
46 | MP0002837_dystrophic_cardiac_calcinosis | 1.71661085 |
47 | MP0005423_abnormal_somatic_nervous | 1.70918245 |
48 | MP0003763_abnormal_thymus_physiology | 1.68355777 |
49 | MP0003787_abnormal_imprinting | 1.67977150 |
50 | MP0001502_abnormal_circadian_rhythm | 1.66236819 |
51 | MP0004883_abnormal_blood_vessel | 1.65844851 |
52 | MP0003183_abnormal_peptide_metabolism | 1.65005472 |
53 | MP0003879_abnormal_hair_cell | 1.64936318 |
54 | MP0002909_abnormal_adrenal_gland | 1.55965526 |
55 | MP0005464_abnormal_platelet_physiology | 1.55321015 |
56 | MP0002405_respiratory_system_inflammati | 1.54842228 |
57 | MP0002876_abnormal_thyroid_physiology | 1.54804334 |
58 | MP0004215_abnormal_myocardial_fiber | 1.49254997 |
59 | MP0000716_abnormal_immune_system | 1.48486974 |
60 | MP0004947_skin_inflammation | 1.44213314 |
61 | MP0002398_abnormal_bone_marrow | 1.41754281 |
62 | MP0002557_abnormal_social/conspecific_i | 1.41504841 |
63 | MP0001845_abnormal_inflammatory_respons | 1.40839401 |
64 | MP0004381_abnormal_hair_follicle | 1.39355581 |
65 | MP0000569_abnormal_digit_pigmentation | 1.36913253 |
66 | MP0003633_abnormal_nervous_system | 1.34939786 |
67 | MP0002184_abnormal_innervation | 1.34732629 |
68 | MP0005451_abnormal_body_composition | 1.34630933 |
69 | MP0009764_decreased_sensitivity_to | 1.33061335 |
70 | MP0005164_abnormal_response_to | 1.32982120 |
71 | MP0000751_myopathy | 1.32219034 |
72 | MP0006276_abnormal_autonomic_nervous | 1.31497883 |
73 | MP0010155_abnormal_intestine_physiology | 1.30084053 |
74 | MP0004811_abnormal_neuron_physiology | 1.29773942 |
75 | MP0008872_abnormal_physiological_respon | 1.29701366 |
76 | MP0003329_amyloid_beta_deposits | 1.27684829 |
77 | MP0004742_abnormal_vestibular_system | 1.27383860 |
78 | MP0001851_eye_inflammation | 1.24806162 |
79 | MP0002166_altered_tumor_susceptibility | 1.23424307 |
80 | MP0005166_decreased_susceptibility_to | 1.22360800 |
81 | MP0004142_abnormal_muscle_tone | 1.20582675 |
82 | MP0002132_abnormal_respiratory_system | 1.20151457 |
83 | MP0005535_abnormal_body_temperature | 1.19480837 |
84 | MP0000465_gastrointestinal_hemorrhage | 1.17960134 |
85 | MP0002998_abnormal_bone_remodeling | 1.16799320 |
86 | MP0009278_abnormal_bone_marrow | 1.15260271 |
87 | MP0005645_abnormal_hypothalamus_physiol | 1.15243396 |
88 | MP0005551_abnormal_eye_electrophysiolog | 1.13870252 |
89 | MP0008874_decreased_physiological_sensi | 1.13378762 |
90 | MP0002277_abnormal_respiratory_mucosa | 1.13090376 |
91 | MP0002066_abnormal_motor_capabilities/c | 1.12752876 |
92 | MP0003631_nervous_system_phenotype | 1.12674600 |
93 | MP0005671_abnormal_response_to | 1.12076185 |
94 | MP0001835_abnormal_antigen_presentation | 1.11211695 |
95 | MP0000689_abnormal_spleen_morphology | 1.10643906 |
96 | MP0001188_hyperpigmentation | 1.10496903 |
97 | MP0000920_abnormal_myelination | 1.10039096 |
98 | MP0010386_abnormal_urinary_bladder | 1.09265772 |
99 | MP0002722_abnormal_immune_system | 1.09057570 |
100 | MP0001529_abnormal_vocalization | 1.06755227 |
101 | MP0008961_abnormal_basal_metabolism | 1.06742803 |
102 | MP0008469_abnormal_protein_level | 1.06206672 |
103 | MP0002429_abnormal_blood_cell | 1.03806666 |
104 | MP0004858_abnormal_nervous_system | 1.02360574 |
105 | MP0003656_abnormal_erythrocyte_physiolo | 0.99844804 |
106 | MP0000015_abnormal_ear_pigmentation | 0.97950878 |
107 | MP0005310_abnormal_salivary_gland | 0.96574109 |
108 | MP0000955_abnormal_spinal_cord | 0.94786064 |
109 | MP0002882_abnormal_neuron_morphology | 0.94719177 |
110 | MP0002332_abnormal_exercise_endurance | 0.94714983 |
111 | MP0002396_abnormal_hematopoietic_system | 0.94572065 |
112 | MP0000703_abnormal_thymus_morphology | 0.93369161 |
113 | MP0004036_abnormal_muscle_relaxation | 0.91470459 |
114 | MP0005174_abnormal_tail_pigmentation | 0.91044644 |
115 | MP0004130_abnormal_muscle_cell | 0.88849638 |
116 | MP0004484_altered_response_of | 0.88644656 |
117 | MP0005397_hematopoietic_system_phenotyp | 0.87531710 |
118 | MP0001545_abnormal_hematopoietic_system | 0.87531710 |
119 | MP0004145_abnormal_muscle_electrophysio | 0.87243200 |
120 | MP0004085_abnormal_heartbeat | 0.86389487 |
121 | MP0000858_altered_metastatic_potential | 0.85669721 |
122 | MP0003045_fibrosis | 0.85048527 |
123 | MP0002163_abnormal_gland_morphology | 0.83674222 |
124 | MP0001905_abnormal_dopamine_level | 0.83109699 |
125 | MP0004084_abnormal_cardiac_muscle | 0.81688394 |
126 | MP0002006_tumorigenesis | 0.80133103 |
127 | MP0005387_immune_system_phenotype | 0.79811516 |
128 | MP0001790_abnormal_immune_system | 0.79811516 |
129 | MP0001348_abnormal_lacrimal_gland | 0.79330577 |
130 | MP0003137_abnormal_impulse_conducting | 0.78631114 |
131 | MP0003690_abnormal_glial_cell | 0.78344729 |
132 | MP0003075_altered_response_to | 0.78081425 |
133 | MP0002069_abnormal_eating/drinking_beha | 0.77696955 |
134 | MP0000778_abnormal_nervous_system | 0.77332294 |
135 | MP0000604_amyloidosis | 0.77004142 |
136 | MP0008004_abnormal_stomach_pH | 0.76211300 |
137 | MP0002229_neurodegeneration | 0.75663259 |
138 | MP0009333_abnormal_splenocyte_physiolog | 0.75503572 |
139 | MP0002090_abnormal_vision | 0.75478463 |
140 | MP0000343_altered_response_to | 0.73919031 |
141 | MP0002148_abnormal_hypersensitivity_rea | 0.72289195 |
142 | MP0000249_abnormal_blood_vessel | 0.71333546 |
143 | MP0002638_abnormal_pupillary_reflex | 0.69572439 |
144 | MP0003303_peritoneal_inflammation | 0.67897299 |
145 | MP0003632_abnormal_nervous_system | 0.66434685 |
146 | MP0001986_abnormal_taste_sensitivity | 0.66369770 |
147 | MP0002972_abnormal_cardiac_muscle | 0.66125348 |
148 | MP0003172_abnormal_lysosome_physiology | 0.61078592 |
149 | MP0000013_abnormal_adipose_tissue | 0.59085499 |
150 | MP0005620_abnormal_muscle_contractility | 0.58936950 |
151 | MP0003866_abnormal_defecation | 0.57482896 |
152 | MP0009785_altered_susceptibility_to | 0.56935949 |
153 | MP0002152_abnormal_brain_morphology | 0.54543919 |
154 | MP0005167_abnormal_blood-brain_barrier | 0.53919740 |
155 | MP0008260_abnormal_autophagy | 0.53579905 |
156 | MP0005379_endocrine/exocrine_gland_phen | 0.52959784 |
157 | MP0005084_abnormal_gallbladder_morpholo | 0.52242844 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.44452859 |
2 | Febrile seizures (HP:0002373) | 5.73841842 |
3 | Eczematoid dermatitis (HP:0000976) | 5.55312947 |
4 | Epileptic encephalopathy (HP:0200134) | 5.50141104 |
5 | Recurrent bacterial skin infections (HP:0005406) | 5.43915256 |
6 | Myokymia (HP:0002411) | 5.33140585 |
7 | Atonic seizures (HP:0010819) | 5.24040063 |
8 | Focal seizures (HP:0007359) | 5.17549095 |
9 | Recurrent abscess formation (HP:0002722) | 5.11646477 |
10 | Myositis (HP:0100614) | 5.06019613 |
11 | Orchitis (HP:0100796) | 5.01792991 |
12 | Progressive cerebellar ataxia (HP:0002073) | 4.97638755 |
13 | Visual hallucinations (HP:0002367) | 4.52678396 |
14 | Dysmetric saccades (HP:0000641) | 4.36600688 |
15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.19236368 |
16 | Abnormality of macrophages (HP:0004311) | 4.16738503 |
17 | Absence seizures (HP:0002121) | 4.15137021 |
18 | Gaze-evoked nystagmus (HP:0000640) | 4.06251152 |
19 | Stomatitis (HP:0010280) | 4.02428913 |
20 | Hyperventilation (HP:0002883) | 3.96766742 |
21 | Recurrent fungal infections (HP:0002841) | 3.80954604 |
22 | Dialeptic seizures (HP:0011146) | 3.79952073 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.76802467 |
24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76448352 |
25 | Generalized tonic-clonic seizures (HP:0002069) | 3.73286326 |
26 | Action tremor (HP:0002345) | 3.72884247 |
27 | Broad-based gait (HP:0002136) | 3.66544532 |
28 | Keratoconjunctivitis sicca (HP:0001097) | 3.59854176 |
29 | Recurrent skin infections (HP:0001581) | 3.59425732 |
30 | T lymphocytopenia (HP:0005403) | 3.51518688 |
31 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.42658838 |
32 | Mediastinal lymphadenopathy (HP:0100721) | 3.42007564 |
33 | Abnormality of T cell number (HP:0011839) | 3.40513066 |
34 | Keratoconjunctivitis (HP:0001096) | 3.37074061 |
35 | Gingivitis (HP:0000230) | 3.37011435 |
36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.33590911 |
37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.33590911 |
38 | Spontaneous hematomas (HP:0007420) | 3.26010790 |
39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.24839252 |
40 | Genetic anticipation (HP:0003743) | 3.24789897 |
41 | Dysdiadochokinesis (HP:0002075) | 3.23081073 |
42 | Poor eye contact (HP:0000817) | 3.22829789 |
43 | Truncal ataxia (HP:0002078) | 3.19748157 |
44 | Meningitis (HP:0001287) | 3.16050125 |
45 | Abnormal hair whorl (HP:0010721) | 3.08401662 |
46 | Scanning speech (HP:0002168) | 3.04656750 |
47 | Vasculitis (HP:0002633) | 3.00332047 |
48 | Encephalitis (HP:0002383) | 2.98751131 |
49 | Impaired social interactions (HP:0000735) | 2.97882876 |
50 | Abnormal social behavior (HP:0012433) | 2.97882876 |
51 | Amyloidosis (HP:0011034) | 2.95192151 |
52 | Hemoptysis (HP:0002105) | 2.94764645 |
53 | Gingival bleeding (HP:0000225) | 2.86609389 |
54 | Postural instability (HP:0002172) | 2.86556075 |
55 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83291507 |
56 | Chest pain (HP:0100749) | 2.81007286 |
57 | Depression (HP:0000716) | 2.80737816 |
58 | Obstructive lung disease (HP:0006536) | 2.79904508 |
59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.79904508 |
60 | Hemiplegia (HP:0002301) | 2.78980487 |
61 | Impaired smooth pursuit (HP:0007772) | 2.76214069 |
62 | Pulmonary infiltrates (HP:0002113) | 2.73184000 |
63 | Progressive inability to walk (HP:0002505) | 2.72736197 |
64 | Dysmetria (HP:0001310) | 2.72412594 |
65 | Arterial thrombosis (HP:0004420) | 2.70685535 |
66 | Pheochromocytoma (HP:0002666) | 2.69230016 |
67 | Peritonitis (HP:0002586) | 2.63678251 |
68 | Abnormal eating behavior (HP:0100738) | 2.60967401 |
69 | Urticaria (HP:0001025) | 2.60963387 |
70 | Leukocytosis (HP:0001974) | 2.58686729 |
71 | Slow saccadic eye movements (HP:0000514) | 2.58202733 |
72 | Diplopia (HP:0000651) | 2.57407023 |
73 | Abnormality of binocular vision (HP:0011514) | 2.57407023 |
74 | Episodic fever (HP:0001954) | 2.57121258 |
75 | Status epilepticus (HP:0002133) | 2.55894372 |
76 | Anxiety (HP:0000739) | 2.50553779 |
77 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.50263070 |
78 | Neuroendocrine neoplasm (HP:0100634) | 2.48540166 |
79 | Drooling (HP:0002307) | 2.48245911 |
80 | Excessive salivation (HP:0003781) | 2.48245911 |
81 | Pulmonary embolism (HP:0002204) | 2.47559690 |
82 | Epileptiform EEG discharges (HP:0011182) | 2.45252369 |
83 | Central scotoma (HP:0000603) | 2.41035991 |
84 | Prolonged bleeding time (HP:0003010) | 2.39336154 |
85 | Abnormality of T cells (HP:0002843) | 2.37370567 |
86 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.36071039 |
87 | Vertigo (HP:0002321) | 2.35710936 |
88 | Prolonged QT interval (HP:0001657) | 2.35094760 |
89 | Epistaxis (HP:0000421) | 2.28821781 |
90 | Pustule (HP:0200039) | 2.28160803 |
91 | Cellulitis (HP:0100658) | 2.26180718 |
92 | Subacute progressive viral hepatitis (HP:0006572) | 2.25745500 |
93 | Ventricular fibrillation (HP:0001663) | 2.25400961 |
94 | Atrial fibrillation (HP:0005110) | 2.24723040 |
95 | Bundle branch block (HP:0011710) | 2.24691462 |
96 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23725961 |
97 | Syncope (HP:0001279) | 2.23153358 |
98 | Recurrent viral infections (HP:0004429) | 2.22791242 |
99 | Failure to thrive in infancy (HP:0001531) | 2.22772877 |
100 | Abnormality of saccadic eye movements (HP:0000570) | 2.21051432 |
101 | Primary atrial arrhythmia (HP:0001692) | 2.20774684 |
102 | Protruding tongue (HP:0010808) | 2.20392268 |
103 | Ankle clonus (HP:0011448) | 2.19303860 |
104 | Blue irides (HP:0000635) | 2.18954392 |
105 | Abnormal EKG (HP:0003115) | 2.18778862 |
106 | Inflammation of the large intestine (HP:0002037) | 2.18637263 |
107 | Hypochromic microcytic anemia (HP:0004840) | 2.17543809 |
108 | Increased IgE level (HP:0003212) | 2.16331470 |
109 | Anorexia (HP:0002039) | 2.15979323 |
110 | Abnormality of the endocardium (HP:0004306) | 2.14936860 |
111 | Inability to walk (HP:0002540) | 2.14886119 |
112 | Supranuclear gaze palsy (HP:0000605) | 2.14620744 |
113 | Amblyopia (HP:0000646) | 2.14418082 |
114 | Retrobulbar optic neuritis (HP:0100654) | 2.13783810 |
115 | Optic neuritis (HP:0100653) | 2.13783810 |
116 | Osteomyelitis (HP:0002754) | 2.13358905 |
117 | Bradykinesia (HP:0002067) | 2.13159030 |
118 | Hypsarrhythmia (HP:0002521) | 2.08372737 |
119 | Hypochromic anemia (HP:0001931) | 2.06878408 |
120 | Torticollis (HP:0000473) | 2.06147661 |
121 | Gangrene (HP:0100758) | 2.05566098 |
122 | Sudden death (HP:0001699) | 2.05501551 |
123 | Impaired vibratory sensation (HP:0002495) | 2.04989841 |
124 | Supraventricular tachycardia (HP:0004755) | 2.02862753 |
125 | Polyphagia (HP:0002591) | 2.02646108 |
126 | Increased cerebral lipofuscin (HP:0011813) | 2.00614216 |
127 | Stomach cancer (HP:0012126) | 2.00527394 |
128 | Gastrointestinal inflammation (HP:0004386) | 1.99755292 |
129 | Generalized hypopigmentation of hair (HP:0011358) | 1.99459915 |
130 | Abnormality of the pleura (HP:0002103) | 1.99201382 |
131 | Fetal akinesia sequence (HP:0001989) | 1.98824572 |
132 | Mutism (HP:0002300) | 1.98503524 |
133 | Stereotypic behavior (HP:0000733) | 1.97981540 |
134 | Hemiparesis (HP:0001269) | 1.94819892 |
135 | Eosinophilia (HP:0001880) | 1.94414796 |
136 | Supraventricular arrhythmia (HP:0005115) | 1.93251597 |
137 | Memory impairment (HP:0002354) | 1.91601674 |
138 | Viral hepatitis (HP:0006562) | 1.88943353 |
139 | Colitis (HP:0002583) | 1.87216741 |
140 | Hypothermia (HP:0002045) | 1.87089182 |
141 | Limb ataxia (HP:0002070) | 1.86876543 |
142 | Oligomenorrhea (HP:0000876) | 1.86704885 |
143 | Focal dystonia (HP:0004373) | 1.86646783 |
144 | Spinal canal stenosis (HP:0003416) | 1.86407031 |
145 | Granulocytopenia (HP:0001913) | 1.86291447 |
146 | Papilledema (HP:0001085) | 1.85303351 |
147 | Bradycardia (HP:0001662) | 1.85238879 |
148 | Autoimmune thrombocytopenia (HP:0001973) | 1.84736138 |
149 | Difficulty running (HP:0009046) | 1.84706620 |
150 | Fair hair (HP:0002286) | 1.84083306 |
151 | Incomplete penetrance (HP:0003829) | 1.84056504 |
152 | Lower limb amyotrophy (HP:0007210) | 1.82372830 |
153 | Increased IgM level (HP:0003496) | 1.82271589 |
154 | Abnormality of the peritoneum (HP:0002585) | 1.81693453 |
155 | Recurrent bronchitis (HP:0002837) | 1.81288193 |
156 | Myotonia (HP:0002486) | 1.80916118 |
157 | Psychosis (HP:0000709) | 1.79894690 |
158 | Cheilitis (HP:0100825) | 1.79272193 |
159 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.78477063 |
160 | Absent speech (HP:0001344) | 1.75848779 |
161 | Abnormality of the lower motor neuron (HP:0002366) | 1.74993453 |
162 | Sepsis (HP:0100806) | 1.74155065 |
163 | Abnormality of salivation (HP:0100755) | 1.73605215 |
164 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73397565 |
165 | Glomerulopathy (HP:0100820) | 1.72925968 |
166 | Exercise-induced myalgia (HP:0003738) | 1.71568791 |
167 | Gait ataxia (HP:0002066) | 1.70126137 |
168 | Abnormality of pain sensation (HP:0010832) | 1.69963452 |
169 | Impaired pain sensation (HP:0007328) | 1.69963452 |
170 | Intention tremor (HP:0002080) | 1.67243406 |
171 | Gait imbalance (HP:0002141) | 1.67181589 |
172 | Generalized myoclonic seizures (HP:0002123) | 1.67068762 |
173 | Hypoventilation (HP:0002791) | 1.66368739 |
174 | Left ventricular hypertrophy (HP:0001712) | 1.63557810 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 3.74100470 |
2 | NTRK3 | 3.49386304 |
3 | MAP3K9 | 3.19476173 |
4 | BLK | 3.18732030 |
5 | MAP3K12 | 3.10122828 |
6 | DAPK2 | 2.95441554 |
7 | MAP2K7 | 2.77265908 |
8 | MAP3K4 | 2.74182632 |
9 | EPHA4 | 2.68661586 |
10 | IRAK4 | 2.48930170 |
11 | RIPK4 | 2.45514696 |
12 | MAP3K13 | 2.43587124 |
13 | MAP4K1 | 2.38851683 |
14 | CSK | 2.32839575 |
15 | SIK3 | 2.18310849 |
16 | MAP2K3 | 2.00730680 |
17 | DAPK1 | 1.91868456 |
18 | MAP3K14 | 1.91540041 |
19 | MAP2K4 | 1.87150256 |
20 | MINK1 | 1.78325582 |
21 | FGR | 1.76311719 |
22 | GRK6 | 1.73508830 |
23 | CAMKK2 | 1.71721733 |
24 | ZAP70 | 1.69651120 |
25 | NTRK2 | 1.69144611 |
26 | CDK19 | 1.67845328 |
27 | TAOK3 | 1.66124198 |
28 | SGK2 | 1.65992372 |
29 | CAMKK1 | 1.62873374 |
30 | ARAF | 1.55170244 |
31 | KSR2 | 1.53518675 |
32 | PAK6 | 1.53426930 |
33 | EPHB1 | 1.52181841 |
34 | PRPF4B | 1.50435637 |
35 | AKT3 | 1.42833367 |
36 | INSRR | 1.39970460 |
37 | SGK3 | 1.36464785 |
38 | BTK | 1.34554178 |
39 | SGK223 | 1.33202616 |
40 | SGK494 | 1.33202616 |
41 | HCK | 1.33013027 |
42 | MARK2 | 1.29239098 |
43 | STK38 | 1.27180344 |
44 | BMPR2 | 1.25544149 |
45 | NTRK1 | 1.24740513 |
46 | PLK2 | 1.24446999 |
47 | MAP3K11 | 1.22200968 |
48 | MAP3K3 | 1.21188729 |
49 | ERN1 | 1.20516073 |
50 | ITK | 1.16533192 |
51 | GRK5 | 1.16463257 |
52 | CDK5 | 1.13363802 |
53 | SIK2 | 1.12773396 |
54 | MARK1 | 1.11776562 |
55 | LYN | 1.11356692 |
56 | IRAK1 | 1.08956550 |
57 | KSR1 | 1.07750535 |
58 | PIK3CG | 1.06594651 |
59 | JAK1 | 1.03517270 |
60 | CSF1R | 1.02994808 |
61 | FES | 1.00666897 |
62 | LCK | 0.98426043 |
63 | YES1 | 0.93059021 |
64 | STK11 | 0.92489722 |
65 | PINK1 | 0.91011709 |
66 | FRK | 0.90219728 |
67 | MAPK13 | 0.89884062 |
68 | PRKCG | 0.87632556 |
69 | CAMK2A | 0.87083217 |
70 | KIT | 0.86227093 |
71 | SGK1 | 0.84765505 |
72 | TNK2 | 0.83141543 |
73 | TGFBR2 | 0.82833113 |
74 | IRAK2 | 0.82558501 |
75 | TEC | 0.81378530 |
76 | TBK1 | 0.81219898 |
77 | PHKG2 | 0.80423621 |
78 | PHKG1 | 0.80423621 |
79 | LMTK2 | 0.79622605 |
80 | PDK1 | 0.78260105 |
81 | CCNB1 | 0.78138946 |
82 | PRKCH | 0.78085239 |
83 | MARK3 | 0.76958454 |
84 | MATK | 0.76409456 |
85 | TNIK | 0.74923387 |
86 | RET | 0.73443108 |
87 | PTK6 | 0.71663010 |
88 | MAP3K1 | 0.70722304 |
89 | PRKCE | 0.68925621 |
90 | CAMK1 | 0.68271322 |
91 | FGFR3 | 0.67652812 |
92 | ACVR1B | 0.67510678 |
93 | CAMK4 | 0.67387850 |
94 | IKBKB | 0.65301012 |
95 | MAPK7 | 0.63963347 |
96 | WNK1 | 0.62303319 |
97 | SYK | 0.61917421 |
98 | RAF1 | 0.60927746 |
99 | MYLK | 0.59196781 |
100 | MAP3K7 | 0.59193222 |
101 | ERBB2 | 0.58696406 |
102 | PTK2B | 0.57123588 |
103 | PRKD3 | 0.56965208 |
104 | NLK | 0.56878667 |
105 | JAK2 | 0.56733248 |
106 | PDPK1 | 0.56718177 |
107 | BCR | 0.54494696 |
108 | PRKCQ | 0.53861262 |
109 | CDC42BPA | 0.53245866 |
110 | MUSK | 0.51642594 |
111 | IKBKE | 0.50665856 |
112 | TAOK1 | 0.50012096 |
113 | OXSR1 | 0.49972908 |
114 | MAP3K6 | 0.49588286 |
115 | TSSK6 | 0.49562714 |
116 | BRAF | 0.49514913 |
117 | GRK7 | 0.49436349 |
118 | RPS6KA2 | 0.48010976 |
119 | DAPK3 | 0.47200551 |
120 | MAP3K5 | 0.47001176 |
121 | RIPK1 | 0.46960043 |
122 | CDK18 | 0.46700764 |
123 | PAK3 | 0.46292864 |
124 | FGFR4 | 0.46188656 |
125 | PDGFRB | 0.45899393 |
126 | MAPK12 | 0.45235152 |
127 | CAMK1D | 0.42959967 |
128 | EPHA3 | 0.42048476 |
129 | CAMK2D | 0.41340496 |
130 | JAK3 | 0.41101890 |
131 | RPS6KA3 | 0.40984225 |
132 | NEK1 | 0.39974837 |
133 | CDK15 | 0.39498607 |
134 | FYN | 0.38157565 |
135 | RPS6KB1 | 0.37213207 |
136 | DMPK | 0.35155384 |
137 | TXK | 0.34218412 |
138 | CAMK2B | 0.32979390 |
139 | NEK6 | 0.32653616 |
140 | MAP3K2 | 0.32150306 |
141 | CDK14 | 0.32139316 |
142 | TYK2 | 0.31214611 |
143 | PRKCZ | 0.31048664 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.49355138 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.30213141 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.51907966 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.42577665 |
5 | Morphine addiction_Homo sapiens_hsa05032 | 2.41643457 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40319543 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.40308081 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37448266 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.25069806 |
10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19777479 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16073837 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07483404 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 1.90250859 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 1.87152742 |
15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.86194082 |
16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.86109664 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.83949483 |
18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.69649021 |
19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67420404 |
20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.66554515 |
21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65839890 |
22 | Taste transduction_Homo sapiens_hsa04742 | 1.65119787 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63121539 |
24 | Renin secretion_Homo sapiens_hsa04924 | 1.56768854 |
25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53572557 |
26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51522000 |
27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44468988 |
28 | Long-term depression_Homo sapiens_hsa04730 | 1.44271735 |
29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44172347 |
30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43685741 |
31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40313543 |
32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39832404 |
33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.38505166 |
34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.33776311 |
35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28862829 |
36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24669293 |
37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24026165 |
38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22047558 |
39 | Malaria_Homo sapiens_hsa05144 | 1.21491392 |
40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20184119 |
41 | Platelet activation_Homo sapiens_hsa04611 | 1.19902155 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18096659 |
43 | Measles_Homo sapiens_hsa05162 | 1.16694742 |
44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13548361 |
45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12527095 |
46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10622293 |
47 | Legionellosis_Homo sapiens_hsa05134 | 1.10205771 |
48 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09899393 |
49 | Influenza A_Homo sapiens_hsa05164 | 1.08482951 |
50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.08291625 |
51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05720602 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04473034 |
53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04169362 |
54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04094195 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01545443 |
56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01349885 |
57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98623839 |
58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97058434 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96195289 |
60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93581494 |
61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93136645 |
62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91942831 |
63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91280464 |
64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90280136 |
65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90086329 |
66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88340812 |
67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88102300 |
68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83290930 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83262275 |
70 | Gap junction_Homo sapiens_hsa04540 | 0.82447211 |
71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82168432 |
72 | Phototransduction_Homo sapiens_hsa04744 | 0.80865845 |
73 | Pertussis_Homo sapiens_hsa05133 | 0.80568261 |
74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80519779 |
75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80015505 |
76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79528335 |
77 | Hepatitis B_Homo sapiens_hsa05161 | 0.79526213 |
78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77392514 |
79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76815272 |
80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76627878 |
81 | Asthma_Homo sapiens_hsa05310 | 0.76075226 |
82 | Allograft rejection_Homo sapiens_hsa05330 | 0.74881473 |
83 | Glioma_Homo sapiens_hsa05214 | 0.74593143 |
84 | Hepatitis C_Homo sapiens_hsa05160 | 0.74326246 |
85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74241416 |
86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73240539 |
87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73067839 |
88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72893448 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72757303 |
90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71665349 |
91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71327585 |
92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70204280 |
93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64054711 |
94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62964226 |
95 | Endocytosis_Homo sapiens_hsa04144 | 0.61334174 |
96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60804253 |
97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60715509 |
98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59249098 |
99 | Apoptosis_Homo sapiens_hsa04210 | 0.59165971 |
100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58955440 |
101 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58942805 |
102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58639807 |
103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58473597 |
104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58331695 |
105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58167467 |
106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54736509 |
107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54532904 |
108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54273105 |
109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50835214 |
110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47697085 |
111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47633136 |
112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.47137183 |
113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45980509 |
114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44366862 |
115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43453436 |
116 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41780224 |
117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41671219 |
118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41191176 |
119 | Tuberculosis_Homo sapiens_hsa05152 | 0.40833967 |
120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40532873 |
121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40435633 |
122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39838751 |
123 | Bile secretion_Homo sapiens_hsa04976 | 0.38939455 |
124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38808499 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37399133 |
126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37155943 |
127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35375153 |
128 | Melanogenesis_Homo sapiens_hsa04916 | 0.34978944 |
129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34719424 |
130 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34652393 |
131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34474057 |
132 | Phagosome_Homo sapiens_hsa04145 | 0.34331385 |
133 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34210595 |
134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33705156 |
135 | Axon guidance_Homo sapiens_hsa04360 | 0.33065066 |
136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32287461 |
137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32246237 |